Regulus Therapeutics  logo
Regulus Therapeutics RGLS
report update icon

Quarterly report 2025-Q1
added 11-21-2026

Regulus Therapeutics ROE Ratio | RGLS

Annual ROE Ratio Regulus Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
-60.67 -141.77 -85.08 -50.6 -60.44 -92.89 832.06 -204.18 -145.94 -44.93 -42.93 -19.97 -28.04 - 44.85 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
832.06 -204.18 -7.18

Quarterly ROE Ratio Regulus Therapeutics

2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-49.27 -35.31 -73.36 -84.85 -94.23 -113.21 -95.57 -86.92 -83.42 -70.22 -62.79 -73.49 -72.75 -81.28 -73.38 -49.5 -114.04 -114.68 -134.04 3664.12 3639.29 3645.82 3816.54 -626.78 -653.75 -707.51 -894.82 -276.38 -251.73 -233.37 -228.05 -222.32 -138.1 -106.18 -76.3 -59.77 -51.79 -41.88 -52.85 -55.75 -54.47 -58.41 -43.68 -33.46 -33.77 -32.9 -41.91 -27.8 -17.08 -7.76 8.16 -0.43 -3.62 4.86 2.52 - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
3816.54 -894.82 148.84

ROE Ratio of other stocks in the Biotechnology industry

Issuer ROE Ratio Price % 24h Market Cap Country
NuCana plc NuCana plc
NCNA
-120.66 $ 0.75 4.39 % $ 8.42 B britainBritain
Novartis AG Novartis AG
NVS
30.0 $ 150.51 -0.47 % $ 292 B schweizSchweiz
Puma Biotechnology Puma Biotechnology
PBYI
23.87 $ 7.05 -1.05 % $ 353 M usaUSA
Fulcrum Therapeutics Fulcrum Therapeutics
FULC
-8.43 $ 3.69 -0.67 % $ 281 M usaUSA
PDS Biotechnology Corporation PDS Biotechnology Corporation
PDSB
-81.75 $ 0.79 -2.58 % $ 36.6 M usaUSA
Geron Corporation Geron Corporation
GERN
-36.97 $ 0.87 -4.76 % $ 580 M usaUSA
Pharming Group N.V. Pharming Group N.V.
PHAR
22.12 $ 11.54 -5.18 % $ 7.95 B niderlandNiderland
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
0.05 $ 4.65 -8.46 % $ 339 M usaUSA
Genmab A/S Genmab A/S
GMAB
21.38 $ 50.36 -1.93 % $ 3.26 B danmarkDanmark
Gossamer Bio Gossamer Bio
GOSS
138.78 $ 10.69 -4.81 % $ 2.44 B usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
2.47 $ 8.14 -0.73 % $ 5.53 B spainSpain
Liquidia Corporation Liquidia Corporation
LQDA
-154.03 $ 54.39 -3.96 % $ 4.68 B usaUSA
GlaxoSmithKline plc GlaxoSmithKline plc
GSK
39.41 $ 47.8 -0.05 % $ 194 B britainBritain
MediciNova MediciNova
MNOV
28.85 $ 1.3 2.36 % $ 63.8 M usaUSA
PTC Therapeutics PTC Therapeutics
PTCT
-332.66 $ 56.23 -3.59 % $ 4.47 B usaUSA
Pulmatrix Pulmatrix
PULM
-32.64 $ 1.24 -12.34 % $ 4.53 B usaUSA
InflaRx N.V. InflaRx N.V.
IFRX
-109.81 $ 1.05 -3.67 % $ 70.7 M germanyGermany
Immunome Immunome
IMNM
-33.48 $ 15.69 -5.54 % $ 1.37 B usaUSA
Immuron Limited Immuron Limited
IMRN
-64.64 $ 0.9 5.87 % $ 208 M australiaAustralia
Incyte Corporation Incyte Corporation
INCY
24.9 $ 114.5 -1.19 % $ 22.4 B usaUSA
INmune Bio INmune Bio
INMB
-195.54 $ 0.82 -8.41 % $ 20.3 M usaUSA
Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Limited
RDY
16.98 $ 14.88 0.24 % $ 12.4 B indiaIndia
Regeneron Pharmaceuticals Regeneron Pharmaceuticals
REGN
14.41 $ 920.38 -0.22 % $ 96.3 B usaUSA
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
-77.98 $ 26.58 -2.37 % $ 4.25 B usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
63.85 $ 1.06 -10.92 % $ 48.4 M israelIsrael
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
-9.17 $ 4.68 -0.53 % $ 757 M usaUSA
Kala Pharmaceuticals Kala Pharmaceuticals
KALA
-385.65 $ 2.73 -9.61 % $ 22.2 M usaUSA
Intellia Therapeutics Intellia Therapeutics
NTLA
-61.47 $ 10.02 5.24 % $ 1.09 B usaUSA
Adagene Adagene
ADAG
-49.82 $ 1.8 -10.56 % $ 106 M chinaChina
Denali Therapeutics Denali Therapeutics
DNLI
-50.56 $ 18.43 1.29 % $ 3.18 B usaUSA
Pfizer Pfizer
PFE
8.99 $ 27.4 -0.62 % $ 156 B usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
-8.45 $ 10.56 -6.26 % $ 4.38 B irlandaIrlanda
ImmuCell Corporation ImmuCell Corporation
ICCC
-3.84 $ 11.08 -0.81 % $ 100 M usaUSA
Editas Medicine Editas Medicine
EDIT
-586.56 $ 1.63 -4.68 % $ 145 M usaUSA
Kiniksa Pharmaceuticals, Ltd. Kiniksa Pharmaceuticals, Ltd.
KNSA
10.4 $ 93.83 0.32 % $ 6.96 B usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
-34.62 $ 27.54 -4.24 % $ 1.6 B usaUSA
Royalty Pharma plc Royalty Pharma plc
RPRX
7.94 $ 68.45 1.08 % $ 29.4 B usaUSA
Equillium Equillium
EQ
-78.32 $ 1.06 -5.36 % $ 60.7 M usaUSA
Black Diamond Therapeutics Black Diamond Therapeutics
BDTX
19932.98 $ 1.32 -5.04 % $ 75.1 M usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
-44.71 $ 2.42 -1.17 % $ 128 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
31.86 $ 17.1 -2.79 % $ 2.88 B usaUSA
Atossa Therapeutics Atossa Therapeutics
ATOS
-88.35 $ 1.6 -8.86 % $ 13.8 M usaUSA
Cleveland BioLabs, Inc. Cleveland BioLabs, Inc.
CBLI
-119.12 - -7.31 % $ 49 M usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
-0.14 $ 112.31 -3.84 % $ 7.3 B usaUSA
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc.
FPRX
-31.81 - - $ 1.77 B usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
76.74 $ 1.29 -2.28 % $ 164 M schweizSchweiz
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
18.24 $ 32.58 -1.21 % $ 1.87 B usaUSA
Ardelyx Ardelyx
ARDX
-37.14 $ 2.99 -2.25 % $ 721 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
-16.25 $ 0.39 -8.41 % $ 100 M usaUSA
Alector Alector
ALEC
-466.57 $ 2.34 1.52 % $ 241 M usaUSA